


Healthcare News Roundup: Venture Capital
HSMN NewsFeed - 28 Oct 2015
Turnstone Biologics Completes Series A Financing Led by Versant Ventures, Strengthens Management Team
Turnstone Biologics Completes Series A Financing Led by Versant Ventures, Strengthens Management Team
HSMN NewsFeed - 28 Oct 2015
Personal Genome Diagnostics Secures $21.4 Million in Series A Financing Led By New Enterprise Associates
Personal Genome Diagnostics Secures $21.4 Million in Series A Financing Led By New Enterprise Associates
HSMN NewsFeed - 26 Oct 2015
Cardionomic Raises $20 Million in Series A Financing to Develop Heart Failure Therapy
Cardionomic Raises $20 Million in Series A Financing to Develop Heart Failure Therapy
HSMN NewsFeed - 23 Oct 2015
Sequana Medical AG Raises CHF 9 million (USD 9.3M) in a Series C Extension
Sequana Medical AG Raises CHF 9 million (USD 9.3M) in a Series C Extension
HSMN NewsFeed - 20 Oct 2015
Silk Road Medical Announces up to $57 Million in New Funding for Novel Approach to Preventing Strokes
Silk Road Medical Announces up to $57 Million in New Funding for Novel Approach to Preventing Strokes
HSMN NewsFeed - 8 Oct 2015
Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies
Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies
HSMN NewsFeed - 1 Oct 2015
Neon Therapeutics Launches with $55 Million Series A to Develop Neoantigen-based Cancer Immunotherapies
Neon Therapeutics Launches with $55 Million Series A to Develop Neoantigen-based Cancer Immunotherapies
HSMN NewsFeed - 23 Sep 2015
XENiOS(R) Receives Cash Infusion from Existing Investors to Expand Commercial Operations in US and Europe
XENiOS(R) Receives Cash Infusion from Existing Investors to Expand Commercial Operations in US and Europe
HSMN NewsFeed - 21 Sep 2015
CASI Pharmaceuticals to Raise $25.1 Million in Private Placement of Common Stock and Warrants
CASI Pharmaceuticals to Raise $25.1 Million in Private Placement of Common Stock and Warrants
HSMN NewsFeed - 21 Sep 2015
Deciphera Pharmaceuticals Announces $75 Million Series B Financing to Advance Novel Oncology Pipeline
Deciphera Pharmaceuticals Announces $75 Million Series B Financing to Advance Novel Oncology Pipeline
